Back to Royal Bank of Canada Royal Bank of Canada

NTLA

28 quarters

Position history for Royal Bank of CanadaRoyal Bank of Canada's holdings in Intellia Therapeutics, Inc.

Yes. Royal Bank of Canada holds 673,340 shares of NTLA (Intellia Therapeutics), worth $11.4M, as of its Q2 2026 13F filing. It increased the position by 207,841 shares (+44.7%) from Q1 2026. Royal Bank of Canada has held NTLA in every 13F on record since Q3 2019, 28 quarterly filings.

Current Value

$11.4M

Current Shares

673,340

Total Value Change

+$9.6M

Total Shares Change

+541,495

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
673,340
+44.6%
$11.4M0.0%$16.92
38
2026-Q1
Increased
465,499
+1082.1%
$6M0.0%$12.82
44
2025-Q4
Decreased
39,378
-91.5%
$355,0000.0%$8.99
0
2025-Q3
Decreased
464,527
-8.0%
$8M0.0%$17.27
0
2025-Q2
Increased
504,774
+1643.8%
$4.7M0.0%$9.38
43
2025-Q1
Decreased
28,946
-23.1%
$206,0000.0%$7.11
0
2024-Q4
Decreased
37,644
-67.0%
$439,0000.0%$11.66
0
2024-Q3
Decreased
114,134
-0.5%
$2.3M0.0%$20.55
0
2024-Q2
Decreased
114,716
-0.3%
$2.6M0.0%$22.38
0
2024-Q1
Decreased
115,100
-25.1%
$3.2M0.0%$27.51
0
2023-Q4
Increased
153,612
+83.8%
$4.7M0.0%$30.49
42
2023-Q3
Increased
83,556
+151.6%
$2.6M0.0%$31.62
42
2023-Q2
Increased
33,212
+19.2%
$1.4M0.0%$40.78
30
2023-Q1
Decreased
27,866
-23.1%
$1M0.0%$37.27
0
2022-Q4
Increased
36,222
+89.9%
$1.3M0.0%$34.89
40
2022-Q3
Decreased
19,072
-5.9%
$1.1M0.0%$55.96
0
2022-Q2
Decreased
20,276
-34.0%
$1M0.0%$51.76
0
2022-Q1
Decreased
30,707
-3.8%
$2.2M0.0%$72.67
0
2021-Q4
Increased
31,913
+34.4%
$3.8M0.0%$118.24
34
2021-Q3
Increased
23,741
+5.2%
$3.2M0.0%$134.15
28
2021-Q2
Decreased
22,563
-6.3%
$3.7M0.0%$161.91
0
2021-Q1
Decreased
24,068
-80.9%
$1.9M0.0%$80.26
0
2020-Q4
Increased
126,180
+0.5%
$6.9M0.0%$54.40
27
2020-Q3
Decreased
125,497
-1.7%
$2.5M0.0%$19.88
0
2020-Q2
Increased
127,618
+7.2%
$2.7M0.0%$21.02
28
2020-Q1
Decreased
119,038
-3.9%
$1.5M0.0%$12.23
0
2019-Q4
Decreased
123,853
-6.1%
$1.8M0.0%$14.67
0
2019-Q3
First report
131,845
-
$1.8M0.0%$13.35
0

Other major holders of NTLA: ARK Investment Management LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used